Research ArticleClinical Investigations
Correlation of Intraprostatic Tumor Extent with 68Ga-PSMA Distribution in Patients with Prostate Cancer
Kambiz Rahbar, Matthias Weckesser, Sebastian Huss, Axel Semjonow, Hans-Jörg Breyholz, Andres J. Schrader, Michael Schäfers and Martin Bögemann
Journal of Nuclear Medicine April 2016, 57 (4) 563-567; DOI: https://doi.org/10.2967/jnumed.115.169243
Kambiz Rahbar
1Department of Nuclear Medicine, University Hospital Muenster, Muenster, Germany
Matthias Weckesser
1Department of Nuclear Medicine, University Hospital Muenster, Muenster, Germany
Sebastian Huss
2Gerhard Domagk Institute of Pathology, University Hospital Muenster, Muenster, Germany
Axel Semjonow
3Prostate Center, Department for Urology, University Hospital Muenster, Muenster, Germany
Hans-Jörg Breyholz
1Department of Nuclear Medicine, University Hospital Muenster, Muenster, Germany
Andres J. Schrader
3Prostate Center, Department for Urology, University Hospital Muenster, Muenster, Germany
Michael Schäfers
1Department of Nuclear Medicine, University Hospital Muenster, Muenster, Germany
4European Institute for Molecular Imaging, University of Muenster, Muenster, Germany; and
5Cells-in-Motion Cluster of Excellence, University of Muenster, Muenster, Germany
Martin Bögemann
3Prostate Center, Department for Urology, University Hospital Muenster, Muenster, Germany
In this issue
Journal of Nuclear Medicine
Vol. 57, Issue 4
April 1, 2016
Correlation of Intraprostatic Tumor Extent with 68Ga-PSMA Distribution in Patients with Prostate Cancer
Kambiz Rahbar, Matthias Weckesser, Sebastian Huss, Axel Semjonow, Hans-Jörg Breyholz, Andres J. Schrader, Michael Schäfers, Martin Bögemann
Journal of Nuclear Medicine Apr 2016, 57 (4) 563-567; DOI: 10.2967/jnumed.115.169243
Correlation of Intraprostatic Tumor Extent with 68Ga-PSMA Distribution in Patients with Prostate Cancer
Kambiz Rahbar, Matthias Weckesser, Sebastian Huss, Axel Semjonow, Hans-Jörg Breyholz, Andres J. Schrader, Michael Schäfers, Martin Bögemann
Journal of Nuclear Medicine Apr 2016, 57 (4) 563-567; DOI: 10.2967/jnumed.115.169243
Jump to section
Related Articles
Cited By...
- A Prostate-Specific Membrane Antigen PET-Based Approach for Improved Diagnosis of Prostate Cancer in Gleason Grade Group 1: A Multicenter Retrospective Study
- Analysing the tumor transcriptome of prostate cancer to predict efficacy of Lu-PSMA therapy
- Tumor Detection of 18F-PSMA-1007 in the Prostate Gland in Patients with Prostate Cancer Using Prostatectomy Specimens as Reference Method
- Head-to-Head Comparison of 68Ga-PSMA-11 with 18F-PSMA-1007 PET/CT in Staging Prostate Cancer Using Histopathology and Immunohistochemical Analysis as a Reference Standard
- qPSMA: Semiautomatic Software for Whole-Body Tumor Burden Assessment in Prostate Cancer Using 68Ga-PSMA11 PET/CT
- Detection Rate of 18F-Choline PET/CT and 68Ga-PSMA-HBED-CC PET/CT for Prostate Cancer Lymph Node Metastases with Direct Link from PET to Histopathology: Dependence on the Size of Tumor Deposits in Lymph Nodes
- Combination of 68Ga-PSMA PET/CT and Multiparametric MRI Improves the Detection of Clinically Significant Prostate Cancer: A Lesion-by-Lesion Analysis
- EBONI: A Tool for Automated Quantification of Bone Metastasis Load in PSMA PET/CT
- Immunohistochemical Validation of PSMA Expression Measured by 68Ga-PSMA PET/CT in Primary Prostate Cancer
- Intraindividual Comparison of 18F-PSMA-1007 PET/CT, Multiparametric MRI, and Radical Prostatectomy Specimens in Patients with Primary Prostate Cancer: A Retrospective, Proof-of-Concept Study
- PSMA Ligands for PET Imaging of Prostate Cancer
- Phase 2 Study of 99mTc-Trofolastat SPECT/CT to Identify and Localize Prostate Cancer in Intermediate- and High-Risk Patients Undergoing Radical Prostatectomy and Extended Pelvic LN Dissection
- Prostate-Specific Membrane Antigen Ligands for Imaging and Therapy
- 68Ga-PSMA-11 PET as a Gatekeeper for the Treatment of Metastatic Prostate Cancer with 223Ra: Proof of Concept
- German Multicenter Study Investigating 177Lu-PSMA-617 Radioligand Therapy in Advanced Prostate Cancer Patients
- What Medical, Urologic, and Radiation Oncologists Want from Molecular Imaging of Prostate Cancer
- Response and Tolerability of a Single Dose of 177Lu-PSMA-617 in Patients with Metastatic Castration-Resistant Prostate Cancer: A Multicenter Retrospective Analysis